Abstract The number of recreational/non-elite athletes participating in marathons is increasing, but data regarding impact of endurance exercise on cardiovascular health are conflicting. This study evaluated 79 recreational athletes of the 2016 Barcelona Marathon (72% men; mean age 39 ± 6 years; 71% ≥35 years). Blood samples were collected at baseline (24-48 h before the race), immediately after the race (1-2 h after the race), and 48-h post-race. Amino-terminal pro-B type natriuretic peptide (NT-proBNP, a marker of myocardial strain), ST2 (a marker of extracellular matrix remodeling and fibrosis, inflammation, and myocardial strain), and high-sensitivity troponin T (hs-TnT, a marker of myocyte stress/injury) were assayed. The median (interquartile range, IQR) years of training was 7 (5-11) years and median (IQR) weekly training hours was 6 (5-8) h/week, respectively. The median (IQR) race time (h:min:s) was 3:32:44 (3:18:50-3:51:46). Echocardiographic indices were within normal ranges. Immediately after the race, blood concentration of the three cardiac biomarkers increased significantly, with 1.3-, 1.6-, and 16-fold increases in NT-proBNP, ST2, and hs-TnT, respectively. We found an inverse relationship between weekly training hours and increased ST2 (p = 0.007), and a direct relationship between race time and increased hs-TnT (p < 0.001) and ST2 (p = 0.05). Our findings indicate that preparation for and participation in marathon running may affect multiple pathways affecting the cardiovascular system. More data and longterm follow-up studies in non-elite and elite athletes are needed.
The number of recreational/non-elite athletes participating in marathons is increasing, but data regarding impact of endurance exercise on cardiovascular health are conflicting [1] . Strenuous exercise may increase the circulating concentrations of cardiac biomarkers that are used to monitor heart health and disease. Here, we examined dynamics of a panel of cardiac biomarkers in non-elite athletes completing the Barcelona Marathon in 2016.
The local ethics committee approved the study, and all participants provided written informed consent. The study sample included 79 recreational athletes (72% men; mean age 39 ± 6 years; 71% ≥ 35 years) who responded to a call for volunteers (http:// www.emmaroca.com/es/forms/estudi-cientific-perfil-delultrafondista/). Blood samples were collected at baseline (24-48 h before the race), immediately after the race (1-2 h after the race), and 48-h post-race. Biomarkers were measured using commercially available assays for amino-terminal pro-B type natriuretic peptide (NT-proBNP, a marker of myocardial strain), ST2 (a marker of extracellular matrix remodeling and fibrosis, inflammation, and myocardial strain) [2] , and high-sensitivity troponin T (hs-TnT, a marker of myocyte stress/injury).
The median (interquartile range, IQR) years of training was 7 (5-11) years and median (IQR) weekly training hours was 6 (5-8) h/week, respectively. The median (IQR) race time (hours:min:sec) was 3:32:44 (3:18:50-3:51:46). Echocardiographic indices measured after the race were within normal ranges (left ventricular (LV) ejection fraction 62 ± 5%; LV end diastolic diameter 50 ± 5 mm; indexed LV mass 94 ± 20 g/body surface area; tricuspid annular plane systolic excursion 26 ± 3 mm).
Although not the focus of the present report, we also measured creatinine phosphokinase (CK) as a marker of skeletal muscle breakdown. CK increased from a baseline level of 165 U/L (125-239 U/L) to 518 U/L (377-709 U/L) immediately postrace and 692 U/L (462-1032) at 48 h (both p < 0.001 relative to pre-race values). CK dynamics were not associated with age, years of training, weekly hours of training, or performance of the athletes. Table 1 shows biomarker values. A significant number of runners had ST2 (48.7%) and hs-TnT (10.4%) concentrations above accepted cutoff point for individuals without cardiac disease at baseline and 48-h post-race. Baseline hs-TnT correlated directly with weekly training hours (p = 0.01) and correlated inversely with race completion time (p = 0.009). None of the biomarkers at baseline correlated with years of training or weekly training hours.
Immediately after the race, blood concentration of the three cardiac biomarkers increased significantly, with 1.3-, 1.6-, and 16-fold increases in NT-proBNP, ST2, and hs-TnT, respectively (Table 1 ; all p < 0.001). NT-proBNP and ST2 concentrations returned to baseline 48 h after the race, while hs-TnT concentrations remained 60% higher than baseline levels ( Table 1 , p < 0.001). Age and years of training showed no significant relationships with the dynamics of the biomarkers. However, we found an inverse relationship between weekly training hours and increased ST2 (p = 0.007), and a direct relationship between race time and increased hs-TnT (p < 0.001) and ST2 (p = 0.05). In multivariable linear regression analyses that included age, sex, and variables with a p value ≤0.10 in correlation analyses, race time remained independently associated with elevations in ST2 (p = 0.03) and hs-TnT (p < 0.001) levels.
Our findings indicate preparation for and participation in marathon running may affect multiple physiological pathways, and further studies using a larger panel of biomarkers are required in order to define the role of biomarkers in these non-elite athletes. The mechanism of release and prognostic meaning of abnormal concentration of these biomarkers remains uncertain. In athletes completing the Boston Marathon, increase in NT-proBNP and TnT (non-highly sensitive) correlated with post-race diastolic dysfunction, increased pulmonary pressures, and right ventricular dysfunction [3] . On the other hand, in non-marathon settings, these biomarkers confer long-term increased risk for myocardial infarction and cardiovascular death in individuals without symptoms of cardiovascular disease [4] . Among our trained recreational athletes, NT-proBNP concentrations modestly rose and fell; however, the substantial percentage of those with elevated ST2 concentrations together with huge release of hsTnT during the race (along with persistently high circulating levels post-race) is noteworthy and could indicate exerciseinduced myocyte injury, possibly due to mechanisms such as volume or pressure overload, myocardial strain, or direct myocyte toxicity. To our knowledge, our data are pioneer regarding endurance sports-driven ST2 increases in amateur runners; whether such release might be responsible for longterm extracellular matrix remodeling and, ultimately, adverse ventricular remodeling remains unclear. Ultimately, ST2 origin in endurance sports is unclear. Besides the heart, ST2 may have arisen from the microvasculature as endothelial cells are known to release ST2, or the lungs, as pulmonary sources of ST2 are also possible, or healing skeletal muscle may also be a source in marathon runners. Further research is needed to better understand ST2 pathobiology in endurance sports.
Marathon running and other endurance sports are increasingly popular, raising concerns about sports-driven adverse cardiac injury. More data and long-term follow-up studies in non-elite and elite athletes are needed. Nevertheless, excessive elaboration of cardiac biomarkers may emerge as Philippides surrogates, named for the Greek messenger who experienced sudden death after running more than 175 miles in 2 days.
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